IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,004,745 | +97.9% | 126,323 | +135.3% | 0.00% | – |
| Q2 2023 | $1,013,055 | +135.0% | 53,686 | -40.3% | 0.00% | – |
| Q4 2018 | $431,000 | -97.4% | 89,863 | -94.8% | 0.00% | -100.0% |
| Q2 2018 | $16,901,000 | -39.9% | 1,737,000 | -35.0% | 0.01% | -35.7% |
| Q1 2018 | $28,114,000 | +45.9% | 2,672,400 | -11.1% | 0.01% | +55.6% |
| Q4 2017 | $19,272,000 | -10.4% | 3,006,600 | +7.0% | 0.01% | -18.2% |
| Q3 2017 | $21,503,000 | +747.9% | 2,810,900 | +197.0% | 0.01% | +1000.0% |
| Q3 2016 | $2,536,000 | -13.0% | 946,301 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $2,915,000 | -63.8% | 946,301 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $8,062,000 | -37.2% | 946,301 | 0.0% | 0.00% | -42.9% |
| Q4 2015 | $12,841,000 | +41.4% | 946,301 | 0.0% | 0.01% | +75.0% |
| Q3 2015 | $9,084,000 | -27.7% | 946,301 | +8.3% | 0.00% | -33.3% |
| Q2 2015 | $12,569,000 | – | 874,050 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |